Public can have say on latest oil drilling update
The decision to approve an oilfield in Biscathorpe was quashed in July last year following a Supreme Court judgement after a claim had been brought in by SOS Biscathorpe.
Last year, justices at the Supreme Court said emissions created by burning fossil fuels should be considered when granting planning permission for new drilling sites.
The public have until 28 July to submit their opinions on further information submitted by the developer, Egdon Resources, on the potential climate impact of burning extracted oil.
Mark Abbott, chief executive officer at Edgon Resources, said the company had submitted an assessment of the greenhouse gas emissions at the request of the Planning Inspectorate.
The documents can be viewed on the planning applications portal on Lincolnshire County Council's website.
The application for an oil well at Biscathorpe was initially refused by Lincolnshire County Council in 2021, but the company successfully appealed it before it was taken to the High Court.
SOS Biscathorpe, which has been fighting the plans for years, said the development "delivers almost nothing for national energy security, while threatening the integrity of one of Lincolnshire's most treasured natural areas".
Mr Abbott said: "Although we are in transition away from fossil fuels, we are still highly reliant on oil and gas for transportation, heating our homes and running our businesses."
According to the Local Democracy Reporting Service, Egdon Resources previously said it could potentially extract 6.5 million barrels of oil over 15 years at the site.
People wanting to submit their opinions can do so by writing to the Planning Inspectorate using the Planning Inspectorate Portal on its website, a document on the appeal application stated.
Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Wolds oil drilling plans quashed in landmark ruling
Oil drilling decision questioned at High Court
'National need' for oil justifies drilling decision
Decision still awaited on oil drilling appeal
Biscathorpe oil drilling appeal
Planning Inspectorate
Egdon Resources
SOS Biscathorpe
Local Democracy Reporting Service
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Holiday park expansion refusal appeal is dismissed
An appeal against a refusal to expand a luxury holiday park has been dismissed by the planning inspectorate. The owners of Overstone Park Resort near Northampton wanted to add 77 holiday units to the 120 that already existed at the site. West Northamptonshire Council turned down the application last year, but the owners appealed the decision. The government's Planning Inspectorate said the placement of 32 of the lodges on the eastern edge of the park would impact the "natural beauty [and] relative tranquillity" of the site. The plans were met with criticism from members of the public at the time, attracting about 150 objections and disapproval from the Lodge Owners' Association, the Local Democracy Reporting Service said. Overstone Park is a long-established golf resort complex, with a members' clubhouse, 115 lodges, tennis courts and a bowling green. Councillors refused the expansion plans on the basis that they would harm the character and appearance of the area, intrude on the designated green wedge and disturb the setting of heritage assets at the Overstone Hall estate. The Planning Inspectorate's report found the additional two-storey lodges proposed for the western edge of the park would undermine its visual and historical relationship within the setting of Overstone Hall. Overstone Park Resort previously said the expansion would help turn it into a luxury destination and allow further investment in state-of-the-art amenities. The inspector agreed that the proposal would assist in improving the local tourist offer, leading to increased jobs and spending, as well as securing investment into the golf resort. The report concluded: "Whilst I find that the proposal would contribute positively to the economic and social objectives, it would result in significant environmental harm which would outweigh these benefits. "I therefore conclude that the appeal should be dismissed." Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X. More on this story Holiday park expansion refused after 163 objections Lodge owners oppose golf resort extension plans Related internet links Planning Inspectorate
Yahoo
4 days ago
- Yahoo
Abbott, Siemens Healthineers, and Thermo Fisher Scientific Lead the Market with Innovative Portfolios and Strategic Expansion
The HIV Diagnostics Companies Quadrant report offers an in-depth analysis of the global HIV diagnostics market, assessing over 100 companies and highlighting the Top 14 leaders. Market expansion is driven by rising HIV/AIDS prevalence, point-of-care technological advancements, and awareness campaigns. However, high costs and skilled technician shortages hinder growth. North America leads in market dominance due to its HIV/AIDS prevalence and advanced technologies, while Asia Pacific is projected to grow fastest. Key players like Abbott, Siemens Healthineers, and Thermo Fisher Scientific employ strategies like acquisitions and innovations to maintain strong market positions amid evolving trends. Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "HIV Diagnostics - Company Evaluation Report, 2025" report has been added to HIV Diagnostics Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for HIV Diagnostics. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. 360 Quadrants evaluated over 100 companies, of which the Top 14 HIV Diagnostics Companies were categorized and recognized as the quadrant growth can be attributed to the rising prevalence of HIV/AIDS, the advantages offered by point-of-care instruments & kits, and increasing initiatives for HIV awareness campaigns. However, the high cost of NATs, operational barriers, and the shortage of skilled laboratory technicians are key factors restraining the market growth. The high growth potential of emerging economies and the trend of self-testing are expected to provide lucrative opportunities for market players during the forecast HIV diagnostics market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America dominated the global market in 2023. Factors such as the rising prevalence of HIV/AIDS, advancements in PoC instruments and kits, increasing awareness about HIV/AIDS, and increasing blood transfusion and blood donations are driving the growth of the HIV diagnostics market in North the Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The high growth rate of the Asia Pacific market can be attributed to the rising target patient population; the expansion of emerging economies; the increasing availability of technologically advanced POC products; favorable government initiatives for HIV awareness; and the growing expansion of global players in this Players:Key players in this market include Abbott (US), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland). These players adopt various strategies, such as product launches, expansions, acquisitions, and collaborations, to excel in this (US)Abbott is a leading player in the HIV diagnostics market, known for its impactful Company Product Portfolio that includes FDA- and CE-approved products. The company's strong Company Market Share in the U.S. is complemented by its strategic focus on expanding its presence in emerging markets through varied Company Positioning strategies. By leveraging inorganic growth strategies, such as collaborations and acquisitions, Abbott aims to bolster its Company Healthineers AG (Germany)Siemens Healthineers is a cornerstone in the HIV diagnostics sphere, providing a broad array of medical solutions. Their focus on organic strategies and innovation has allowed them to maintain a competitive Company Positioning. With a significant presence in Europe, America, and emerging markets, they continue to excel in Company Market Share by offering innovative products that meet health sector Fisher Scientific (US)With a comprehensive Company Product Portfolio that spans PCR-based assays and immunoassays, Thermo Fisher Scientific remains a leader. Their strategies focus on regulatory approvals and strategic acquisitions to enhance their Company Market Share. Through collaboration with healthcare organizations, they aim to boost early HIV detection and improve global health access, effectively securing their Company Positioning and Company Ranking in the Topics Covered: 1 Introduction1.1 Market Definition1.2 Inclusions & Exclusions1.3 Stakeholders2 Executive Summary3 Market Overview3.1 Introduction3.2 Market Dynamics3.2.1 Drivers3.2.1.1 Rising Prevalence of Hiv/Aids3.2.1.2 Increasing Number of Blood Transfusions & Blood Donations3.2.1.3 Advantages Offered by Poc Diagnostic Kits & Instruments3.2.1.4 Increasing Initiatives for Hiv Awareness Campaigns3.2.2 Restraints3.2.2.1 High Cost of Nats3.2.3 Opportunities3.2.3.1 High Growth Potential of Emerging Economies3.2.3.2 Trend of Self-Testing and Growing Preference for At-Home Diagnostic Kits3.2.4 Challenges3.2.4.1 Operational Barriers and Shortage of Skilled Laboratory Technicians3.3 Trends/Disruptions Impacting Customers' Businesses3.4 Value Chain Analysis3.5 Supply Chain Analysis3.6 Ecosystem Analysis3.7 Technology Analysis3.7.1 Key Technologies3.7.1.1 Elisa3.7.2 Complementary Technologies3.7.2.1 Western Blot Tests3.7.3 Adjacent Technologies3.7.3.1 Pcr3.8 Patent Analysis3.9 Key Conferences & Events, 2025-20263.10 Porter's Five Forces Analysis3.10.1 Threat of New Entrants3.10.2 Threat of Substitutes3.10.3 Bargaining Power of Buyers3.10.4 Bargaining Power of Suppliers3.10.5 Intensity of Competitive Rivalry3.11 Impact of Ai/Generative Ai on Hiv Diagnostics Market3.11.1 Market Potential of Ai in Hiv Diagnostics3.11.2 Ai Use Cases3.11.3 Company Implementation of Ai3.11.4 Future of Ai/Generative Ai4 Competitive Landscape4.1 Overview4.2 Key Player Strategies/Right to Win4.2.1 Overview of Strategies Adopted by Key Players in Hiv Diagnostics Market4.3 Revenue Analysis, 2021-20234.4 Market Share Analysis, 20234.4.1 Ranking of Key Market Players4.5 Company Evaluation Matrix: Key Players, 20234.5.1 Stars4.5.2 Emerging Leaders4.5.3 Pervasive Players4.5.4 Participants4.5.5 Company Footprint: Key Players, 20234.5.5.1 Company Footprint4.5.5.2 Region Footprint4.5.5.3 Product Footprint4.5.5.4 End-User Footprint4.6 Company Evaluation Matrix: Startups/Smes, 20234.6.1 Progressive Companies4.6.2 Responsive Companies4.6.3 Dynamic Companies4.6.4 Starting Blocks4.6.5 Competitive Benchmarking: Startups/Smes, 20234.6.5.1 Detailed List of Key Startups/Sme Players4.6.5.2 Competitive Benchmarking of Key Startups/Smes4.7 Company Valuation & Financial Metrics4.8 Brand/Product Comparison4.9 Competitive Scenario4.9.1 Product/Service Launches & Approvals4.9.2 Product Launches & Approvals4.9.3 Deals4.9.4 Expansions4.9.5 Other Developments5 Company Profiles Abbott Siemens Healthineers Grifols, S.A. Danaher Corporation Thermo Fisher Scientific Inc. Bio-Rad Laboratories, Inc. F. Hoffmann-La Roche Ltd. Biomerieux Hologic, Inc. Qiagen Bd Trinity Biotech Orasure Technologies, Inc. Biosynex Sa Wondfo Getein Biotech, Inc. Meril Life Sciences Pvt. Ltd. Accubiotech Co., Ltd. Biolytical Laboratories Inc. Bio Lab Diagnostics (I) Private Limited Alpine Biomedicals Pvt Ltd. Molbio Diagnostics Pvt. Ltd. Fortress Diagnostics Advacare Pharma (Accuquik) Adaltis S.R.L. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Yahoo
Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD
The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure. Technological advances in smart devices and telehealth enhance market growth, though high costs and regulatory hurdles pose challenges for new entrants. U.S. Durable Medical Equipment Market Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "United States Durable Medical Equipment Market - Patient Care & Forecast 2025-2033" report has been added to States Durable Medical Equipment Market is expected to grow at a CAGR of 5.03% from 2025 to 2033 to reach US$ 97.10 billion by 2033, from US$ 62.43 billion in 2024 Growth is fueled by increasing chronic disease prevalence, a growing aging population, home healthcare demand, and technologic improvements in mobility aids, monitoring devices, and therapeutic equipment. DME plays a critical function in improving the quality of life for patients with chronic illnesses, disabilities, or convalescing at home following surgery or hospitalization. For example, patient mobility aids such as scooters and crutches assist patients in getting around safely, while respiratory devices provide proper oxygenation for patients with breathing impairments. Hospital beds used at home support and comfort bedridden most insurance programs, including Medicare, DME requires a physician's prescription and determination of medical necessity. Its sole reason for existence is to deliver therapeutic benefit, facilitate independence, and prevent the necessity of prolonged Drivers in the United States Durable Medical Equipment Market Aging Population and Prevalence of Chronic DiseaseThe growing population of older Americans represents a key driver of DME demand. Geriatric populations are typically plagued by illnesses like arthritis, diabetes, and restricted mobility, necessitating devices such as wheelchairs, walkers, and glucose level monitors. As close to 77 million baby boomers reach senior age ranges, the demand for in-home and hospital-grade DME continues to grow. At the same time, chronic diseases afflict more than half of U.S. adults, driving demand for long-term medical support devices. As medical care moves towards proactive and supportive therapy, DME is instrumental in allowing chronically ill and aging populations to preserve the quality of life and remain of Home Healthcare ServicesHome healthcare is increasingly becoming an option of choice for patients, spurred on by increasing hospital bills and the convenience of being treated at home. Durable medical equipment like oxygen concentrators, hospital beds, and nebulizers plays a primary role in home therapies. Medicare, Medicaid, and private insurance pay more for home healthcare services, so DME is more accessible. This is also driven by technological advances that enable remote monitoring and portable medical solutions. More health services are moving out of the clinical setting and into the home, so the market for easy-to-use, small, and safe DME is going to expand dramatically, increasing patient independence and lowering the cost of institutional Advances in Medical DevicesMedical technology innovations are revolutionizing the DME environment, with devices becoming more efficient, lighter, and user-oriented. Innovative products like smart wheelchairs with wayfinding support, wireless glucose meters, and battery-powered suction pumps are more user-friendly and offer better health monitoring. Telehealth and smartphone app integration enables real-time data exchange between patients and caregivers. This has enhanced therapy outcomes and user interaction. Besides this, innovations in materials have resulted in stronger and more comfortable equipment. With patients and clinicians looking for easy-to-use and high-performance devices, manufacturers are investing in R&D, driving the development of next-generation DME solutions in the U.S. States Durable Medical Equipment Market Challenges Exorbitant Costs and Reimbursement ConstraintsThe high initial cost of durable medical equipment usually presents fiscal challenges to patients as well as healthcare providers. While numerous products fall within Medicare and Medicaid coverage, reimbursement is time-consuming and complicated. Limited budgets within healthcare centers and strict insurance requirements frequently prevent timely access to needed devices. Out-of-pocket costs for non-covered or advanced models discourage consumers. Moreover, changes in coverage policies and coding guidelines frequently impact providers' revenue stability. These conditions bring about access inequities and deter entry by new firms because of regulatory obstacles and price Compliance and Quality StandardsManufacturers and vendors of DME are subject to stringent regulations by the FDA, CMS (Centers for Medicare & Medicaid Services), and state health agencies. Compliance with labeling standards, manufacturing standards, and reporting and safety standards can be time-consuming and expensive. Quality-related approval and recall delays can profoundly affect brand reputation and the continuity of operations. Also, the constant need to revise products in order to comply with changing requirements is putting a further strain on R&D and logistics. It becomes challenging for smaller manufacturers to keep up with regulatory demands while competing on innovation and States Medical Wheelchairs MarketThe U.S. medical wheelchair market is increasing at a steady pace with the aging population, mobility disorders, and the increased demand for independent living. Manual and powered wheelchairs are commonly used among elderly people, disabled, and post-operative patients in home and clinical environments. Advances in technology such as powered tilt and recline, lightweight material, and joystick control have improved the comfort and functionality of wheelchairs. Medicare and Medicaid coverage for wheelchair prescriptions also expand accessibility. As orthopedic conditions and rehabilitation demands escalate, particularly in veterans and the elderly, demand for high-quality, tailored wheelchair alternatives also States Commodes and Toilets MarketCommodes and adaptive toilet aids are indispensable for preserving dignity and independence among the elderly and disabled. In the United States, this market is fueled by mounting demand for home care equipment, particularly for mobility or post-operative difficulties. Commodes exist in different configurations such as bedside, drop-arm, and rolling commodes suited to various care requirements. Hospital, nursing home, and home environments are common usage sites. Features like height-adjustable designs, splash guards, and cleanability features have enhanced cleanliness and ease of use. With the rising trend of aging-in-place, sales of commodes will follow suit. Key Players Analysis | Overviews, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis Invacare Corporation NOVA Medical Products Inogen, Inc. Thermo Fisher Scientific Inc. Abbott Medtronic Baxter B. Braun SE Boston Scientific Corporation BD Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $62.43 Billion Forecasted Market Value (USD) by 2033 $97.1 Billion Compound Annual Growth Rate 5.0% Regions Covered United States Key Topics Covered: 1. Introduction2. Research & Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. United States Durable Medical Equipment Market5.1 Historical Market Trends5.2 Market Forecast6. Market Share Analysis6.1 By Product6.2 By End-User6.3 By States7. Product7.1 Personal Mobility Devices7.1.1 Wheelchairs7.1.1.1 Market Analysis7.1.1.2 Market Size & Forecast7.1.2 Scooters7.1.3 Walker and Rollators7.1.4 Canes and Crutches7.1.5 Others7.2 Bathroom Safety Devices and Medical Furniture7.2.1 Commodes and Toilets7.2.2 Mattress and Bedding Devices7.3 Monitoring and Therapeutic Devices7.3.1 Blood Sugar Monitors7.3.2 Continuous Passive Motion (CPM)7.3.3 Infusion Pumps7.3.4 Nebulizers7.3.5 Oxygen Equipment7.3.6 Continuous Positive Airway Pressure (CPAP)7.3.7 Suction Pumps7.3.8 Traction Equipment7.3.9 Others8. End-User8.1 Hospitals8.1.1 Market Analysis8.1.2 Market Size & Forecast8.2 Specialty Clinics8.3 Ambulatory Surgical Centers8.4 Diagnostic Centers8.5 Home Healthcare8.6 Skilled Nursing Facilities8.7 Others9. Top 10 States9.1 California9.1.1 Market Analysis9.1.2 Market Size & Forecast9.2 Texas9.3 New York9.4 Florida9.5 Illinois9.6 Pennsylvania9.7 Ohio9.8 Georgia9.9 Washington9.10 New Jersey9.11 Rest of United States10. Value Chain Analysis11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Competition11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threats13. Pricing Benchmark Analysis13.1 Invacare Corporation13.2 NOVA Medical Products13.3 Inogen, Inc.13.4 Thermo Fisher Scientific Inc.13.5 Abbott13.6 Medtronic13.7 Baxter13.8 B. Braun SE13.9 Boston Scientific Corporation13.10 BD14. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Durable Medical Equipment Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
